| A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Description of wanted capabilities | Find Evidence - > | A user gets information when there are new studies in your focus area... Collaboration.. blah blah ... use FHIR Citation standard, enable federated search.... Use a standardized common terminology for Population and intervention name and description, | Create Living systematic reviews -- > | Create Living guidance --> | ||||||||||||||||||||||
2 | Name | Cochrane Central/COVID-19 Study Register | McMaster PLUS | L·OVE Platform by Epistemonikos Foundation | ACTS COVID-19 Guidance to Action Collaborative - Guidance Summaries | Epistemonikos search database incl. matrix | NIPH - Live map of COVID-19 evidence | GIN guideline library | SRDR - repository | MAGICapp - published guidelines repository | GDTs database of evidence profiles | Eppi-reviewer 4 | RevMan 5 (.rm5) and RevMan Web | Covidence | Rayyan | DistillerSR | GDT | MAGICapp - authoring and publication platform - as a tool | |||||||||
3 | Short explanation (status, what evidence products)-> | The L·OVE Platform gathers and organises health evidence to facilitate access to it. It holds the largest COVID19 evidence collection so far and allows users to conduct basic and advanced searches on evidence of interventions, tests and diagnostics, prevention, among other topics. It considers not only all systematic reviews available, but also primary studies and other kinds of articles, included and not included on the strategies of the different PICO Questions already built in the platform. | |||||||||||||||||||||||||
4 | Target users -> | ||||||||||||||||||||||||||
5 | Read only or can export data | Read + extract through API | Both | ||||||||||||||||||||||||
6 | Link to site | http://covid-19.cochrane.org | app.iloveevidence.com/covid19 | https://covid-acts.ahrq.gov/display/COV/Guidance+Summaries+and+About+This+Project | http://www.epistemonikos.org/ | https://www.fhi.no/en/qk/systematic-reviews-hta/map/ | http://www.g-i-n.net/library/international-guidelines-library | http://srdr.ahrq.gov/ | http://www.magicapp.org | http://dbep.gradepro.org/ | http://eppi.ioe.ac.uk/cms/ | http://tech.cochrane.org/revman | www.covidence.org | http://rayyan.qcri.org | https://www.evidencepartners.com/ | http://www.guidelinedevelopment.org | https://app.magicapp.org | ||||||||||
7 | Owners active in COVID-END | Yes | Yes? | ? | |||||||||||||||||||||||
8 | Ownership | Epistemonikos Foundation | AHRQ | Epistemonikos | NIPH | G-I-N | AHRQ | Magic EE Foundation | McMaster U, Evidence prime | EPPI-Centre, UCL | Cochrane collaboration | Qatar Computing Research Institute | Privately held | Evidence Prime and McMaster University | Magic EE Foundation | ||||||||||||
9 | open access | Yes | No, 1 month free trial | Free for students doing course work | Up to a certain number of profiles | Personal use | |||||||||||||||||||||
10 | Subscription plan/ licensing | The COVID19 L·OVE (collection of evidence) is completely free to access and browse. To obtain/download evidence, free registration is needed. | N/A | N/A | N/A | N/A | N/A | Monthly per user; different options available | Yes, for for-profits | Yes. Monthly per/user subscription. Unlimited reviews | Yes, for for-profits | Only needed for publishing Orgs | |||||||||||||||
11 | Population and intervention elements coded with standard terminology | Both PICO level and recommendation level | User-defined | Both PICO level and recommendation level | |||||||||||||||||||||||
12 | API in place | JSON https://api.epistemonikos.org/ | Programming underway | JSON. http://www.magicapp.org/docs | Yes, but not publicly documented yet | RevMan online | Partial API, undocumented, available soon | ? | JSON. http://www.magicapp.org/docs | ||||||||||||||||||
13 | Use COKA FHIR CItation standard | ||||||||||||||||||||||||||
14 | Use COKA FHIR Evidence standard | ||||||||||||||||||||||||||
15 | Use COKA FHIR EvidenceVariable standard | Can send Outcome definitions | |||||||||||||||||||||||||
16 | Support "Improve my RIS" | N/A | |||||||||||||||||||||||||
17 | Use or contribute to Risk Of Bias Code System (FHIR, COKA) | ||||||||||||||||||||||||||
18 | Use or contribute to Study Design Code System (FHIR, COKA) | ||||||||||||||||||||||||||
19 | Use or contribute to Statistic Type Code System (FHIR, COKA) | ||||||||||||||||||||||||||
20 | Use or contribute to Statistic Model Code System (FHIR, COKA) | ||||||||||||||||||||||||||
21 | Languages available | N/A | 2: en, es | 1: en | 1: en | 14: en, de, no, se, dk, nl, ar, fr, es, fi, pt, ko, zh, ja | 4: en, de, sp, it | 1: en | 1: en | 1: en | 1: en | 1: en | 4: en, de, sp, it | 14: en, de, no, se, dk, nl, ar, fr, es, fi, pt, ko, zh, ja | |||||||||||||
22 | Export files with results data (xml, JSON) | N/A | All date in JSON through API | Yes, xml, html, doc, xls, json etc | Yes, xml | Yes, CSV and RIS with mapped fields. Will ship support for JSON Q1, 2017 | Evidence profiles. | Evidence profiles from app. All other data through API | |||||||||||||||||||
23 | Export files with metadata (xml, JSON) | N/A | Through the API | json | Yes: RIS, BibTeX, EndNote & CSV | Yes, CSV and RIS with mapped fields. Will ship support for JSON Q1, 2018 | Through the API | ||||||||||||||||||||
24 | Export text files | N/A | PDF, Word | Yes? RIS etc?? | Yes. Exports to Word | Yes, PDF and for print | |||||||||||||||||||||
25 | Perform meta-analysis | N/A | |||||||||||||||||||||||||
26 | Perform screening of studies | N/A | No, but plans. | Yes, and full data extraction | |||||||||||||||||||||||
27 | Perform deduplication of studies | N/A | |||||||||||||||||||||||||
28 | Detailed (too detailed) | V | V | V | V | V | V | V | V | V | V | V | V | V | V | V | V | V | V | V | V | V | V | V | V | ||
29 | Non-profit ownership | Yes, as a part of cochrane? | |||||||||||||||||||||||||
30 | Web - Online | ||||||||||||||||||||||||||
31 | Online: Which browsers can be used | all | All | All | All | All, IE down to 6 (but limited design on 6, authoring only 9+) | FF, Safari, Chrome, IE 10+ | V4 requires silverlight (IE / Firefox); Web requires 'modren' browser | All | All (IE9+) | Tested on all major browsers | FF, Safari, Chrome, IE 10+ | All, IE down to 6 (but limited design on 6, authoring only 9+) | ||||||||||||||
32 | Web - Offline | Yes, view only | No? | Yes | View only | ||||||||||||||||||||||
33 | Downloadable | Data exports only | |||||||||||||||||||||||||
34 | Mobile (responsive design or app) | Web UI resizes, though data extraction tricky on a phone (fine on ipad) | |||||||||||||||||||||||||
35 | Many can access at same time, state if limits | Yes, no limit | Yes, no limit | ||||||||||||||||||||||||
36 | Many can author at same time, state if limits | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | No, system of checking in, checking out | |||||||||||||||
37 | Which roles exist, if multiple persons can access | Leader, Consolidator, Contributor, Auditor | Admin, Author, Reviewer, Viewer | Admin / author / read only / multiple Cochrane roles | Private reviews: Owner, Collaborator, Viewer & Translator. Public reviews: Viewer | Detailed permissions matrix for all users to manage roles independantly on each project | Admin, Author, Reviewer, Viewer | ||||||||||||||||||||
38 | GL/ SR -specific chatroom, forum or comments | N/A | No | Yes, comment- sections on all PICOs and recommendations | http://support.rayyan.qcri.org | Yes. Also, live chat-based support | Yes, comment- sections on all PICOs and recommendations | ||||||||||||||||||||
39 | Perform GRADE assessment | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Yes in older, Silverlight version | No, but use evidence profiles made elsewhere | |||||||||||||||
40 | Perform Risk of Bias assessment | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Includes a number of customizable RoB templates | Yes, included in GRADE assessment | Yes, included in GRADE assessment | |||||||||||||
41 | Structured PICO questions | Yes, in matrix of evidence | Yes, through customizable forms | ||||||||||||||||||||||||
42 | Structured Recommendations | No | |||||||||||||||||||||||||
43 | Structured references | Yes | |||||||||||||||||||||||||
44 | Document sharing | No | Yes: realtime collaboration | ||||||||||||||||||||||||
45 | Text mining capabilities (link to site with info) | No, but plans. | http://eppi.ioe.ac.uk/cms/Default.aspx?tabid=3772 | ? | Yes: main business | In develoment. Currently supports keyword highlighting | |||||||||||||||||||||
46 | |||||||||||||||||||||||||||
47 | |||||||||||||||||||||||||||
48 | |||||||||||||||||||||||||||
49 | |||||||||||||||||||||||||||
50 | |||||||||||||||||||||||||||
51 | |||||||||||||||||||||||||||
52 | |||||||||||||||||||||||||||
53 | |||||||||||||||||||||||||||
54 | |||||||||||||||||||||||||||
55 | |||||||||||||||||||||||||||
56 | |||||||||||||||||||||||||||
57 | |||||||||||||||||||||||||||
58 | |||||||||||||||||||||||||||
59 | |||||||||||||||||||||||||||
60 | |||||||||||||||||||||||||||
61 | |||||||||||||||||||||||||||
62 | |||||||||||||||||||||||||||